Financials

  • Market Capitalization 261 M
  • Employee 44
  • Founded 2015
  • CEO N/A
  • Website www.surrozen.com
  • Headquarter Delaware, United States
  • FIGI BBG00XY94S95
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.7
Relación precio/flujo de caja
0.05

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
3417
NAGE
Niagen Bioscience, Inc. - Common Stock
3.37 USD-2.88%-4.26%-3.16%-32.33%268.40 M USD
3432
ALXO
ALX Oncology Holdings Inc. - Common Stock
1.98 USD+0.51%-15.02%+24.53%+330.43%266.43 M USD
3455
RNAC
Cartesian Therapeutics, Inc. - Common Stock
8.95 USD+3.71%-12.77%-7.64%-2.29%262.96 M USD
3470
TRDA
Entrada Therapeutics, Inc. - Common Stock
6.53 USD-1.06%-11.76%-0.91%-6.31%253.50 M USD

Noticias